Target intelligence / Profile preview

Ribosomal protein S17 pseudogene 13 (RPS17P13)

Target: RPS17P13
Molecular classification: Other (Processed pseudogene; not a functional protein, enzyme, transporter, or receptor)

Overview

Ribosomal protein S17 pseudogene 13 (RPS17P13) is one of several processed pseudogenes derived from the functional RPS17 gene, which encodes a structural protein of the small 40S ribosomal subunit. RPS17P13 does not produce a functional protein and has no established biological or therapeutic role. While the functional RPS17 is essential for ribosome assembly and protein synthesis—and mutations in RPS17 can cause Diamond-Blackfan anemia—RPS17P13, like most ribosomal protein pseudogenes, is likely non-functional and is not a recognized therapeutic target[2][6][7][9].

Other names: RPS17P13RPS17_6_804ribosomal protein S17 pseudogene 13

Beyond the preview

Go deeper on Ribosomal protein S17 pseudogene 13 (RPS17P13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S17 pseudogene 13 (RPS17P13).

Explore the full profile